public health
-
COVID-19: What We Know, What Is Still Disputed, and What We Should Learn
Origins, risk by age, the vaccine debate, treatments from remdesivir to monoclonal antibodies, lost trust, censorship and lessons for preppers. Sourced and labeled, then our take, plainly marked as opinion.

